Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylinositol 3-kinase catalytic subunit beta is the Class IA PI3K catalytic isoform p110β that heterodimerizes with p85-type regulatory subunits to phosphorylate phosphatidylinositol 4,5-bisphosphate at the 3-position, generating PIP3 and initiating AKT-dependent signaling cascades that regulate cell growth, proliferation, survival, metabolism, motility, and angiogenesis. It has a unique role in controlling DNA replication through both kinase-dependent signaling (nuclear AKT activation affecting p21Cip and PCNA) and kinase-independent interactions with PCNA that regulate its loading onto chromatin. PI3Kβ also interfaces with GPCR signaling via direct regulation by Gβγ, highlighting its integration of RTK and GPCR inputs within Class I PI3K signaling networks.
Competitive inhibition of the ATP-binding site of PI3K catalytic subunits to block PIP3 production, thereby downregulating AKT/PDK1 signaling and downstream proliferative/survival pathways. Isoform-selective inhibition of Class I PI3Ks to modulate specific cellular functions; structural features enable design of isoform-specific inhibitors.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3-kinase catalytic subunit beta (PI3K-beta (p110β)).